Replies to post #505181 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

Your point actually reinforces what Exwannabe is saying since so much hope has been pinned on the UK and thus there had been not be an issue with accepting the endpoint change.

[dennisdave]

EU/UK and US endpoints do not differ

EU/UK/
The first secondary objective is to compare overall survival (OS) between patients randomized to placebo who received DCVax-L treatment following disease recurrence and control patients from comparable, contemporaneous clinical trials, in patients with recurrent GBM.

US
1. The first secondary objective is to compare overall survival (OS) between patients randomized to placebo who received DCVax-L treatment following disease recurrence, and control patients from comparable, contemporaneous clinical trials, in recurrent GBM.
[ Time Frame: Until death ]

exact the same
It has been stated more than once by the company and LL that the SAP is the same with every RA